|
|
| (73 intermediate revisions by 18 users not shown) |
| Line 1: |
Line 1: |
| {{Infobox_Disease | | | __NOTOC__ |
| Name = Hyperkalemia |
| | {| class="infobox" style="float:right;" |
| Image = K-TableImage.png |
| | |- |
| Caption = [[potassium]] |
| | | [[File:Siren.gif|30px|link=Hyperkalemia resident survival guide]]|| <br> || <br> |
| DiseasesDB = 6242 |
| | | [[Hyperkalemia resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] |
| ICD10 = {{ICD10|E|87|5|e|70}} |
| | |} |
| ICD9 = {{ICD9|276.7}} |
| | {| class="infobox" style="float:right;" |
| ICDO = |
| | |- |
| OMIM = |
| | | [[File:Critical_pathways_.gif|88px|link=Hyperkalemia critical pathways]]|| <br> || <br> |
| MedlinePlus = |
| | |} |
| MeshID = D006947 |
| | |
| }} | | {{Patient}} |
| {{Hyperkalemia}} | | {{Hyperkalemia}} |
| {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org] | | {{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; [[Jogeet Singh Sekhon]] |
| | |
| | ==[[Hyperkalemia overview|Overview]]== |
|
| |
|
| == [[Hyperkalemia overview | Overview]]== | | ==[[Hyperkalemia historical perspective|Historical Perspective]]== |
| ==[[ Hyperkalemia pathophysiology | Pathophysiology ]]==
| |
| ==[[ Hyperkalemia causes | Causes ]]==
| |
| ==[[Hyperkalemia differential diagnosis | Differential diagnosis]]==
| |
| ==[[Hyperkalemia history and symptoms | History and Symptoms ]]==
| |
|
| |
|
| ==Diagnosis== | | ==[[Hyperkalemia classification|Classification]]== |
| In order to gather enough information for diagnosis, the measurement of potassium needs to be repeated, as the elevation can be due to [[hemolysis]] in the first sample. Generally, blood tests for [[renal function]] ([[creatinine]], [[blood urea nitrogen]]), [[glucose]] and occasionally [[creatine kinase]] and [[cortisol]] will be performed. Calculating the [[trans-tubular potassium gradient]] can sometimes help in distinguishing the cause of the hyperkalemia.
| |
|
| |
|
| In many cases, [[medical ultrasonography|renal ultrasound]] will be performed, since hyperkalemia is highly suggestive of renal failure.
| | ==[[Hyperkalemia pathophysiology|Pathophysiology]]== |
|
| |
|
| Also, [[electrocardiography]] (EKG/ECG) may be performed to determine if there is a significant risk of cardiac [[arrhythmias]] (see [[#ECG/EKG Findings|ECG/EKG Findings]], below).
| | ==[[Hyperkalemia causes|Causes]]== |
| ==[[Hyperkalemia lab tests | Lab tests]]== | |
|
| |
|
| ===Electrocardiographic Findings=== | | ==[[Hyperkalemia differential diagnosis|Differentiating Hyperkalemia from other Diseases]]== |
| [[Electrocardiography]] (ECG) is generally done early to identify any influences on the heart, as hyperkalemia may cause fatal [[arrhythmias]]. With moderate hyperkalemia, there is reduction of the size of the P wave and development of tent-shaped T waves. Further hyperkalemia will lead to widening of the [[QRS complex]], that ultimately may become [[sinusoidal]] in shape. There appears to be a direct effect of elevated potassium on some of the potassium channels that increases their activity and speeds membrane repolarization. Also, (as noted [[#Pathophysiology|above]]), hyperkalemia causes an overall membrane depolarization that inactivates many sodium channels. The faster repolarization of the cardiac [[action potential]] causes the tenting of the T waves, and the inactivation of sodium channels causes a sluggish conduction of the electrical wave around the heart, which leads to smaller P waves and widening of the QRS complex.
| |
|
| |
|
| Spcific findings include the following:
| | ==[[Hyperkalemia epidemiology and demographics|Epidemiology and Demographics]]== |
|
| |
|
| ====Tall, narrow, and peaked [[T waves]]==== | | ==[[Hyperkalemia risk factors|Risk Factors]]== |
| * Earliest sign of hyperkalemia
| |
| * Occurs with K > 5.5 meq/li
| |
| * Differential diagnosis of this EKG change includes the T wave changes of [[bradycardia]] or [[stroke]]. Prominent [[U wave]]s and [[QTc]] prolongation are more consistent with [[stroke]] than hyperkalemia.
| |
|
| |
|
| ====Intraventricular conduction defect==== | | ==[[Hyperkalemia screening|Screening]]== |
| #* Observed when K > 6.5 meq/li
| |
| #* There is a modest correlation of the [[QRS]] duration with serum K
| |
| #* As the K rises, the [[QRS]] complexes may resemble sine waves
| |
| #* Generally the widening is diffuse and usually there is no resemblance of the morphology to that of either [[LBBB]] or [[RBBB]]
| |
| ====Decrease of the amplitude of the P wave or an absent P wave====
| |
| * Decreased [[P wave]] amplitude occurs when the K is > 7.0 meq/li
| |
| * [[P wave]]s may be absent when the K is > 8.8 meq/li
| |
| * The impulses are still being generated in the [[SA node]] and are conducted to the ventricles through specialized atrial fibers without depolarizing the atrial muscle
| |
| * Moderate or sever hyperkalemia can cause [[sinus arrest]] <ref name="pmid16792034">{{cite journal |author=Bonvini RF, Hendiri T, Anwar A |title=Sinus arrest and moderate hyperkalemia |journal=[[Annales De Cardiologie Et D'angéiologie]] |volume=55 |issue=3 |pages=161–3 |year=2006 |month=June |pmid=16792034 |doi= |url= |issn=}}</ref>
| |
|
| |
|
| ====ST segment changes simulating current of injury==== | | ==[[Hyperkalemia natural history, complications, and prognosis|Natural history, Complications and Prognosis]]== |
| * Have been labeled the dialyzable current of injury
| |
| ====Cardiac arrhythmias: bradyarrhythmias, tachyarrhythmias, atrioventricular conduction defects====
| |
| * Occurs with severe hyperkalemia, not mild to moderate hyperkalemia
| |
|
| |
|
| <gallery>
| | ==Diagnosis== |
| Image:Hyperkalemia.jpg|Tall, symmetric, narrow based T waves in a hyperkalemic patient.
| | [[Hyperkalemia diagnostic study of choice|Diagnostic study of choice]] | [[Hyperkalemia history and symptoms|History and Symptoms]] | [[Hyperkalemia physical examination|Physical Examination]] | [[Hyperkalemia laboratory findings|Laboratory Findings]] | [[Hyperkalemia electrocardiogram|Electrocardiogram]] | [[Hyperkalemia x ray|X-Ray Findings]] | [[Hyperkalemia echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Hyperkalemia CT scan|CT-Scan Findings]] | [[Hyperkalemia MRI|MRI Findings]] | [[Hyperkalemia other imaging findings|Other Imaging Findings]] | [[Hyperkalemia other diagnostic studies|Other Diagnostic Studies]] |
| Image:Ecg hyperkaliemie.jpg|A patient's EKG with hyperkalemia.
| |
| Image:Ecg hyperkaliemie2.jpg|Same patient's EKG during treatment.
| |
| </gallery>
| |
|
| |
|
| ==Treatment== | | ==Treatment== |
| When arrhythmias occur, or when potassium levels exceed 6.5 mmol/l, emergency lowering of potassium levels is mandated. Several agents are used to lower K levels. Choice depends on the degree and cause of the hyperkalemia, and other aspects of the patient's condition.
| | [[Hyperkalemia medical therapy|Medical Therapy]] | [[Hyperkalemia surgery|Surgery]] | [[Hyperkalemia primary prevention|Primary Prevention]] | [[Hyperkalemia secondary prevention|Secondary Prevention]] | [[Hyperkalemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hyperkalemia future or investigational therapies|Future or Investigational Therapies]] |
| * [[Calcium]] supplementation (calcium gluconate 10% (10ml), preferably through a [[central venous catheter]] as the calcium may cause [[phlebitis]]) does not lower potassium but decreases [[myocardium|myocardial]] excitability, protecting against life threatening [[arrhythmias]].
| |
| * [[Insulin]] (e.g. intravenous injection of 10-15u of (short acting) insulin (e.g. Actrapid) {along with 50ml of 50% dextrose to prevent hypoglycemia}) will lead to a shift of potassium ions into cells, secondary to increased activity of the [[sodium-potassium ATPase]].
| |
| * [[Bicarbonate]] therapy (e.g. 1 ampule (45mEq) infused over 5 minutes) is effective in cases of metabolic acidosis. The bicarbonate ion will stimulate an exchange of cellular H<sup>+</sup> for Na<sup>+</sup>, thus leading to stimulation of the [[sodium-potassium ATPase]].
| |
| * [[Salbutamol]] (albuterol, Ventolin<sup>®</sup>) is a β<sub>2</sub>-selective catacholamine that is administered by nebuliser (e.g. 10-20 mg). This drug promotes movement of K into cells, lowering the blood levels.
| |
| * [[Polystyrene sulfonate]] (Calcium Resonium, Kayexalate) is a binding resin that binds K within the intestine and removes it from the body by defecation. Calcium Resonium (15g three times a day in water) can be given by mouth. Kayexelate can be given by mouth or as an [[enema]]. In both cases, the resin absorbs K within the intestine and carries it out of the body by [[defecation]]. This medication may cause diarrhea.
| |
| * Refractory or severe cases may need [[dialysis]] to remove the potassium from the circulation.
| |
| * Preventing recurrence of hyperkalemia typically involves reduction of dietary potassium, removal of an offending medication, and/or the addition of a [[diuretic]] (such as [[furosemide]] (Lasix<sup>®</sup>) or [[hydrochlorothiazide]]).
| |
|
| |
|
| ==See also== | | ==Case Studies== |
| * [[Hypokalemia]]
| | [[Hyperkalemia case study one|Case #1]] |
| * [[Renal failure]]
| | {{WikiDoc Help Menu}} |
| | {{WikiDoc Sources}} |
|
| |
|
| ==References==
| | [[Category:Emergency medicine]] |
| <references />
| |
| | |
| {{Endocrine, nutritional and metabolic pathology}}
| |
| {{Electrocardiography}}
| |
| | |
| [[Category:Potassium]] | |
| [[Category:Medical emergencies]]
| |
| [[Category:Endocrinology]]
| |
| [[Category:Nephrology]] | | [[Category:Nephrology]] |
| [[Category:Electrolyte disturbance]] | | [[Category:Laboratory tests]] |
| [[Category:Blood tests]]
| |
| [[Category:Emergency medicine]]
| |
| [[Category:Intensive care medicine]]
| |
| | |
| [[de:Hyperkaliämie]]
| |
| [[et:Hüperkaleemia]]
| |
| [[es:Hipercalemia]]
| |
| [[fr:Hyperkaliémie]]
| |
| [[ja:高カリウム血症]]
| |
| [[pl:Hiperkaliemia]]
| |
| [[pt:Hipercaliémia]]
| |
| [[vi:Tăng kali máu]]
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
